Lower Bucks Today

Representatives Brian Fitzpatrick and Joe Morelle have introduced the SCREENS for Cancer Act, a bipartisan initiative designed to enhance access to breast and cervical cancer screenings. The legislation aims to reauthorize the National Breast and Cervical Cancer Early Detection Program (NBCCEDP) through 2030, focusing on expanding services for low-income and underinsured individuals.

Representative Fitzpatrick emphasized the importance of early detection in saving lives, stating, “Every year, too many lives are lost because cancer is detected too late. By modernizing and expanding the National Breast and Cervical Cancer Early Detection Program, we are taking a step forward in removing barriers that prevent too many women—especially those in underserved communities—from getting the screenings that could save their lives.”

Representative Morelle shared his personal connection to the cause: "Cancer has touched my family in the most personal way, and I know firsthand the fear and uncertainty that comes with a diagnosis.” He added that introducing this act with Rep. Fitzpatrick aims to ensure more people receive necessary care.

Molly Guthrie from Susan G. Komen highlighted the bill's potential impact: "Everyone should be able to get the breast health care they need when they need it...This bill will provide access to vital services so that cancers can be caught earlier.” Lisa Lacasse from ACS CAN echoed this sentiment, emphasizing improved access as crucial for ending cancer as we know it.

The NBCCEDP has facilitated over 16.5 million screenings since its inception, diagnosing thousands of invasive cancers. In 2025 alone, significant numbers of new cases and deaths from breast and cervical cancer are expected in the U.S., underscoring the need for enhanced screening efforts.

The SCREENS for Cancer Act proposes several measures including an annual allocation of $235 million through 2030 for NBCCEDP expansion. It also seeks to improve outreach and follow-up care for underserved communities while implementing strategies to boost screening rates.

Additionally, by 2027, a Government Accountability Office study will assess program effectiveness. This initiative aligns with Rep. Fitzpatrick’s ongoing commitment as Co-Chair of the Congressional Cancer Caucus to improve cancer prevention and treatment accessibility across America.